Τόμος 36 (2022) – Τεύχος 1 – Άρθρο 1 – Review of Clinical Pharmacology and Pharmacokinetics -Διεθνής Έκδοση – Volume 36 (2022) – Issue 1 – Article 1 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Dietary supplements: Innocent or potentially carcinogenic Continue reading

Τόμος 36 (2022) – Τεύχος 1 – Άρθρο 4 – Review of Clinical Pharmacology and Pharmacokinetics -Διεθνής Έκδοση – Volume 36 (2022) – Issue 1 – Article 4 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Antioxidant Activity in Patients with Type II Diabetes Continue reading

Τόμος 37 (2023) – Τεύχος 2 – Άρθρο 6 – Review of Clinical Pharmacology and Pharmacokinetics -Διεθνής Έκδοση – Volume 37 (2023) – Issue 2 – Article 6 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Parabens are esters of p-hydroxybenzoic acid and have been used as preservatives for personal care products, pharmaceuticals, cosmetics, and foods attributable to their anti-microbial and anti-fungal properties. Continue reading

Volume 37 (2023) – Issue 2 – Article 4 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Cardiovascular diseases (CVDs) remain a significant global health concern, contributing to substantial morbidity and mortality.
Continue reading

Volume 37 (2023) – Issue 2 – Article 3 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

The purpose of fetal cardiotocography (CTG) is to monitor fetal status during the intrapartum period. Even though CTG is a safe evaluation method, errors in the interpretation of CTG contribute significantly to infant mortality and morbidity. Continue reading

Volume 37 (2023) – Issue 2 – Article 2– Review of Clinical Pharmacology and Pharmacokinetics – International Edition

The global COVID-19 pandemic has posed significant challenges to healthcare systems worldwide. Vulnerable populations, such as individuals with underlying health conditions, are particularly at risk. Continue reading

Volume 37 (2023) – Issue 2 – Article 5 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

The incidence of emerging infectious diseases has increased during the past two decades and is expected to further increase. Continue reading

Volume 37 (2023) – Issue 1 – Article 5 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Diabetes mellitus refers to a group of diseases that affect how the body uses blood sugar (glucose). Glucose is an important source of energy for the cells that make up the muscles and tissues. It’s also the brain’s main source of fuel. Continue reading

Τόμος 37 (2023) – Τεύχος 1 – Άρθρο 4 – Review of Clinical Pharmacology and Pharmacokinetics -Διεθνής Έκδοση – Volume 37 (2023) – Issue 1 – Article 4 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Gynecological oncological complications are short-term or long-term and moreover, some of them are reversible and others irreversible. Continue reading

Volume 37 (2023) – Issue 1 – Article 3 – Review of Clinical Pharmacology and Pharmacokinetics – International Edition

Postnatal depression is a type of depression that many parents experience after having a baby (Wang, 2021). This is not unusual and affects more than 1 in every 10 women within a year of giving birth. Continue reading